A group of investors, including JAZZ Venture Partners, F-Prime Capital, Maverick Ventures, and Andreessen Horowitz, led $40m Series B round in Zus Health, a new wave of healthcare builders to create technologies and services without the usual blockers. "Zus's ability in this market to secure the capital and support they need to really scale their platform is a testament to the potential of the company to create the connective tissue for healthcare. Healthcare has needed a shared patient record for decades at this point, and we believe Zus is our best hope to achieve this vision and help deliver on the promise of technology-enabled care." Andrew Firlik, JAZZ Venture Partners Managing Partner.